BioCentury
ARTICLE | Clinical News

Synovir: Will start Phase II test

April 11, 1994 7:00 AM UTC

Celgene Corp. (CELG), Warren, N.J. Product: Synovir (thalidomide), a suppressor of tumor necrosis factor alpha Indication: Cachexia (wasting) in AIDS Status: Will start in the second quarter a doubl...